SEPARATION AND IDENTIFICATION OF PHASE-I AND PHASE-II [(1)4C]ANTIPYRINE METABOLITES IN RAT AND DOG URINE

被引:12
|
作者
VELIC, I
METZLER, M
HEGE, HG
WEYMANN, J
机构
[1] KNOLL AG,DEPT BIOCHEM,D-67061 LUDWIGSHAFEN,GERMANY
[2] UNIV KAISERSLAUTERN,D-67663 KAISERSLAUTERN,GERMANY
来源
关键词
D O I
10.1016/0378-4347(94)00552-G
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A simple and accurate HPLC procedure was developed to quantify, in a single run, all phase I and phase II [C-14]antipyrine metabolites that occur in rat and dog urine. All metabolites were subjected to thermospray-LC-MS and EI-MS in order to establish their structure. The rat metabolizes antipyrine to eight major metabolites, six of which are conjugated; 1.4% of the dose was excreted unchanged, 18.9% in a free form, 30.6% as sulfates and 21.1% as glucuronides. The dog metabolizes antipyrine to four metabolites, all as sulfate (61.0% of the dose) or glucuronide conjugates (16.2% of the dose).
引用
收藏
页码:139 / 147
页数:9
相关论文
共 50 条
  • [21] CHEMICAL SYNTHESIS OF PHASE-I-METABOLITES AND PHASE-II-METABOLITES OF ANTIPYRINE
    KROHN, K
    STENNS, C
    ARCHIV DER PHARMAZIE, 1989, 322 (06) : 351 - 354
  • [22] Identification of phase-I and phase-II metabolites and the metabolic pathway of the novel synthetic cannabinoid 5F-EDMB-PICA in vitro
    Gao, Yujie
    Shi, Kaiting
    Wang, Peipei
    Liu, Xinyu
    Liu, Chenxi
    Luo, Liya
    Lin, Yanchen
    Yang, Lin
    Yang, Rongji
    Liao, Linchuan
    ARCHIVES OF TOXICOLOGY, 2024, 98 (09) : 2879 - 2888
  • [23] KETAMINE ENHANCES PHASE-I AND PHASE-II NEUROMUSCULAR BLOCK OF SUCCINYLCHOLINE
    TSAI, SK
    LEE, CM
    TRAN, B
    CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 1989, 36 (02): : 120 - 123
  • [24] PHASE-I AND PHASE-II STUDY OF A NEW BLEOMYCIN ANALOG (PEPLEOMYCIN)
    MIURA, T
    KATAYAMA, K
    WADA, T
    RECENT RESULTS IN CANCER RESEARCH, 1981, 76 : 61 - 82
  • [25] PHASE-I - PRELIMINARY PHASE-II TRIAL OF IPROPLATIN, A CISPLATIN ANALOG
    PAOLOZZI, FP
    GAVER, R
    POIESZ, BJ
    LOUIE, A
    DIFINO, S
    COMIS, RL
    NEWMAN, N
    GINSBERG, S
    INVESTIGATIONAL NEW DRUGS, 1988, 6 (03) : 199 - 206
  • [26] PHASE-I PHASE-II INTERACTIONS IN NASCENT POLYOXYBENZOATE LAMELLAR CRYSTALS
    LIU, J
    GEIL, PH
    JOURNAL OF MACROMOLECULAR SCIENCE-PURE AND APPLIED CHEMISTRY, 1993, A30 : 183 - 190
  • [27] PHASE-I, PHASE-II TRIALS OF LENTINAN IN CANCER-PATIENT
    TAGUCHI, T
    INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1980, 2 (03): : 172 - 172
  • [28] CLINICAL DEVELOPMENT OF NAFARELIN ACETATE - PHASE-I AND PHASE-II STUDIES
    HOFFMAN, PG
    HENZL, MR
    CHAPLIN, MD
    NERENBERG, CA
    JOURNAL OF ANDROLOGY, 1987, 8 (01): : S17 - S22
  • [29] A COMPREHENSIVE PHASE-I AND PHASE-II CLINICAL INVESTIGATION OF FLUDARABINE PHOSPHATE
    GREVER, M
    LEIBY, J
    KRAUT, E
    METZ, E
    NEIDHART, J
    BALCERZAK, S
    MALSPEIS, L
    SEMINARS IN ONCOLOGY, 1990, 17 (05) : 39 - 48
  • [30] PHASE-I PHASE-II PREVENTIVE VACCINE TRIALS - CONFERENCE SUMMARY
    WALKER, MC
    FAST, PE
    GRAHAM, BS
    BELSHE, R
    DOLIN, R
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1995, 11 (10) : 1279 - 1285